Latest News: Ardea Biosciences Reports Positive Phase 2a Results For Lead HIV …
March 19th, 2008
March 18, 2008
Clinical Trials / Drug Trials News From Medical News Today
Ardea Biosciences, Inc. (Nasdaq: RDEA) announced positive preliminary results from its ongoing Phase 2a proof-of-concept study of RDEA806, its novel investigational non-nucleoside reverse transcriptas …
Originally Syndicated via RSS from Buzztracker.com - HIV/AIDS
Entry Filed under: Uncategorized
Leave a Comment
You must be logged in to post a comment.
Trackback this post | Subscribe to the comments via RSS Feed